|
CTDSP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.001500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.155200E-01 |
| Normal-vs-Stage2 |
7.94590000000595E-05 |
| Normal-vs-Stage3 |
2.07740000002232E-06 |
| Normal-vs-Stage4 |
7.75250000000227E-05 |
| Stage1-vs-Stage2 |
3.037200E-03 |
| Stage1-vs-Stage3 |
1.155440E-04 |
| Stage1-vs-Stage4 |
2.043800E-03 |
| Stage2-vs-Stage3 |
7.650400E-01 |
| Stage2-vs-Stage4 |
7.677400E-01 |
| Stage3-vs-Stage4 |
9.748400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.632300E-04 |
| Normal-vs-AfricanAmerican |
4.158900E-03 |
| Normal-vs-Asian |
3.713000E-01 |
| Caucasian-vs-AfricanAmerican |
2.633600E-01 |
| Caucasian-vs-Asian |
7.974000E-01 |
| AfricanAmerican-vs-Asian |
5.306200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.994100E-04 |
| Normal-vs-Female |
1.724190E-03 |
| Male-vs-Female |
9.408000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.658810E-01 |
| Normal-vs-Age(41-60Yrs) |
2.012300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.004840E-04 |
| Normal-vs-Age(81-100Yrs) |
1.684190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.284800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.051400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.205000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.840100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.046380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.152000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.935900E-02 |
| Normal-vs-Grade 2 |
2.317800E-01 |
| Normal-vs-Grade 3 |
4.31400000000526E-06 |
| Normal-vs-Grade 4 |
1.52150000043427E-07 |
| Grade 1-vs-Grade 2 |
6.368200E-02 |
| Grade 1-vs-Grade 3 |
6.358400E-04 |
| Grade 1-vs-Grade 4 |
3.804900000004E-05 |
| Grade 2-vs-Grade 3 |
4.558000E-04 |
| Grade 2-vs-Grade 4 |
4.08830000000471E-05 |
| Grade 3-vs-Grade 4 |
6.562400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.640400E-01 |
| Normal-vs-ccB subtype |
1.83320000002318E-06 |
| ccA subtype-vs-ccB subtype |
4.8889999999524E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.400100E-04 |
| Normal-vs-N1 |
1.109560E-01 |
| N0-vs-N1 |
5.687000E-01 |
|
|
